{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:13:05Z","timestamp":1784304785952,"version":"3.55.0"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020871","name":"Abu Dhabi University","doi-asserted-by":"publisher","award":["19300967"],"award-info":[{"award-number":["19300967"]}],"id":[{"id":"10.13039\/100020871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.prp.2026.156398","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:04:35Z","timestamp":1770307475000},"page":"156398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer"],"prefix":"10.1016","volume":"280","author":[{"given":"Afsheen","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf Khursheed","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Moustafa Abo","family":"El-Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4245-7626","authenticated-orcid":false,"given":"Asiya","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s41065-025-00564-8","article-title":"Cancer cell plasticity and therapeutic resistance: mechanisms, crosstalk, and translational perspectives","volume":"162","author":"Ghorbian","year":"2025","journal-title":"Hereditas"},{"issue":"7","key":"10.1016\/j.prp.2026.156398_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","article-title":"Cellular plasticity in cancer","volume":"9","author":"Yuan","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41540-023-00309-1","article-title":"Understanding and leveraging phenotypic plasticity during metastasis formation","volume":"9","author":"Shah","year":"2023","journal-title":"npj Syst. Biol. Appl."},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156398_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12964-024-01643-5","article-title":"Signaling, cancer cell plasticity, and intratumor heterogeneity","volume":"22","author":"Cordani","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12195-021-00694-9","article-title":"Epithelial-to-mesenchymal transition signaling pathways responsible for breast cancer metastasis","volume":"15","author":"Buyuk","year":"2021","journal-title":"Cell. Mol. Bioeng."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Thiery JP: EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.prp.2026.156398_bib8","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1080\/15384101.2019.1648959","article-title":"Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression","volume":"18","author":"Wang","year":"2019","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.prp.2026.156398_bib9","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1002\/jcp.28277","article-title":"The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity","volume":"234","author":"Fardi","year":"2019","journal-title":"J Cell Physiol"},{"issue":"32","key":"10.1016\/j.prp.2026.156398_bib10","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41388-021-01913-3","article-title":"ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/cimb44030079","article-title":"Zinc Finger E-Box Binding Homeobox 2 as a Prognostic Biomarker in Various Cancers and Its Correlation with Infiltrating Immune Cells in Ovarian Cancer","volume":"44","author":"Kim","year":"2022","journal-title":"Curr Issues Mol Biol"},{"issue":"22","key":"10.1016\/j.prp.2026.156398_bib12","doi-asserted-by":"crossref","first-page":"18966","DOI":"10.18632\/oncotarget.3943","article-title":"Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer","volume":"6","author":"Prislei","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3892\/ol.2016.4092","article-title":"Epithelial-mesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer","volume":"11","author":"Wu","year":"2016","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/cr.2011.144","article-title":"Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms","volume":"22","author":"Qin","year":"2012","journal-title":"Cell Res"},{"issue":"22","key":"10.1016\/j.prp.2026.156398_bib16","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/onc.2010.92","article-title":"TWISTing an embryonic transcription factor into an oncoprotein","volume":"29","author":"Ansieau","year":"2010","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.prp.2026.156398_bib17","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.18632\/oncotarget.2428","article-title":"TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis","volume":"5","author":"Nuti","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1039\/C6MD00561F","article-title":"Targeting Twist expression with small molecules","volume":"8","author":"Pei","year":"2017","journal-title":"Medchemcomm"},{"issue":"12","key":"10.1016\/j.prp.2026.156398_bib19","doi-asserted-by":"crossref","first-page":"21621","DOI":"10.3390\/ijms151221621","article-title":"Twist-1 up-regulation in carcinoma correlates to poor survival","volume":"15","author":"Wushou","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjc.6603533","article-title":"Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients","volume":"96","author":"Hosono","year":"2007","journal-title":"Br J Cancer"},{"issue":"24","key":"10.1016\/j.prp.2026.156398_bib21","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/onc.2010.111","article-title":"TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214","volume":"29","author":"Yin","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2026.156398_bib22","doi-asserted-by":"crossref","first-page":"37652","DOI":"10.1038\/srep37652","article-title":"TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling","volume":"6","author":"Roberts","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3892\/ol.2014.1816","article-title":"Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT\/GSK-3\u03b2 signaling pathway","volume":"7","author":"Wang","year":"2014","journal-title":"Oncol Lett"},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078200","article-title":"The role of nuclear \u03b2-catenin accumulation in the Twist2-induced ovarian cancer EMT","volume":"8","author":"Mao","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.prp.2026.156398_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207697","article-title":"The Wnt Signalling Pathway: A Tailored Target in Cancer","volume":"21","author":"Koni","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib26","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-018-04695-7","article-title":"Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface","volume":"9","author":"Tang","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/vaccines3020448","article-title":"Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages","volume":"3","author":"Cannon","year":"2015","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13046-018-0743-1","article-title":"SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT","volume":"37","author":"Liu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41556-018-0062-y","article-title":"PSPC1 mediates TGF-\u03b21 autocrine signalling and Smad2\/3 target switching to promote EMT, stemness and metastasis","volume":"20","author":"Yeh","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.prp.2026.156398_bib30","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.2147\/OTT.S257363","article-title":"CBX6 Promotes HCC Metastasis Via Transcription Factors Snail\/Zeb1-Mediated EMT Mechanism","volume":"13","author":"Wang","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41419-022-04756-2","article-title":"Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial-mesenchymal transition via integrin \u03b21-ILK-SNAIL1 pathway in ovarian cancer","volume":"13","author":"Lu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2004.12.043","article-title":"Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level","volume":"97","author":"Kurrey","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib33","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1159\/000484458","article-title":"Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer","volume":"43","author":"Chen","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib34","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1002\/jcb.26504","article-title":"Mesenchymal splice isoform of CD44 (CD44s) promotes EMT\/invasion and imparts stem-like properties to ovarian cancer cells","volume":"119","author":"Bhattacharya","year":"2018","journal-title":"J Cell Biochem"},{"issue":"10","key":"10.1016\/j.prp.2026.156398_bib35","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.21873\/anticanres.13737","article-title":"Immunohistochemical Analysis of Transcription Factors and Markers of Epithelial-Mesenchymal Transition (EMT) in Human Tumors","volume":"39","author":"Ghulam","year":"2019","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib36","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1080\/21655979.2021.2024319","article-title":"SNAI2 promotes the development of ovarian cancer through regulating ferroptosis","volume":"13","author":"Jin","year":"2022","journal-title":"Bioengineered"},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib37","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/s41388-021-01685-w","article-title":"Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis","volume":"40","author":"Yoon","year":"2021","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib38","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.18632\/oncotarget.14192","article-title":"Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00428-010-0986-5","article-title":"Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients","volume":"457","author":"Hipp","year":"2010","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253112","article-title":"Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study","volume":"16","author":"Parol-Kulczyk","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib41","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s41374-020-0445-0","article-title":"Sox13 promotes hepatocellular carcinoma metastasis by transcriptionally activating Twist1","volume":"100","author":"Feng","year":"2020","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/cas.13186","article-title":"SOX2 is required to maintain cancer stem cells in ovarian cancer","volume":"108","author":"Wen","year":"2017","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40246-019-0241-3","article-title":"Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis","volume":"13","author":"Brusselaers","year":"2019","journal-title":"Hum Genomics"},{"issue":"20","key":"10.1016\/j.prp.2026.156398_bib44","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1111\/jcmm.17557","article-title":"NANOG regulates epithelial-mesenchymal transition via AMPK\/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells","volume":"26","author":"Yun","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib45","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160247","article-title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer","volume":"37","author":"Qin","year":"2017","journal-title":"Biosci Rep"},{"issue":"30","key":"10.1016\/j.prp.2026.156398_bib46","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/onc.2012.363","article-title":"Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers","volume":"32","author":"Siu","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/\u03b2-catenin-driven EMT regulation in human cancers","volume":"81","author":"Xue","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4149\/neo_2021_210103N2","article-title":"CCAAT enhancer binding protein \u03b1 suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt\/\u03b2-catenin signaling","volume":"68","author":"Zhang","year":"2021","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2017.08.010","article-title":"TET1 inhibits EMT of ovarian cancer cells through activating Wnt\/\u03b2-catenin signaling inhibitors DKK1 and SFRP2","volume":"147","author":"Duan","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"292(Pt B):","key":"10.1016\/j.prp.2026.156398_bib50","doi-asserted-by":"crossref","first-page":"118370","DOI":"10.1016\/j.envpol.2021.118370","article-title":"Benzophenone-1 induced aberrant proliferation and metastasis of ovarian cancer cells via activated ER\u03b1 and Wnt\/\u03b2-catenin signaling pathways","author":"Liu","year":"2022","journal-title":"Environ Pollut"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib51","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1038\/s41598-018-27021-z","article-title":"Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer","volume":"8","author":"Hojo","year":"2018","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.prp.2026.156398_bib52","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1111\/jcmm.15491","article-title":"PCNP promotes ovarian cancer progression by accelerating \u03b2-catenin nuclear accumulation and triggering EMT transition","volume":"24","author":"Dong","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"21","key":"10.1016\/j.prp.2026.156398_bib53","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.7150\/jca.62563","article-title":"FAM83A Promotes the Proliferative and Invasive Abilities of Cervical Cancer Cells via Epithelial-Mesenchymal Transition and the Wnt Signaling Pathway","volume":"12","author":"Lan","year":"2021","journal-title":"J Cancer"},{"issue":"20","key":"10.1016\/j.prp.2026.156398_bib54","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.7150\/jca.59595","article-title":"APMAP Promotes Epithelial-Mesenchymal Transition and Metastasis of Cervical Cancer Cells by Activating the Wnt\/\u03b2-catenin Pathway","volume":"12","author":"Zhu","year":"2021","journal-title":"J Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bjc.6604115","article-title":"The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients","volume":"98","author":"Blechschmidt","year":"2008","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib57","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4161\/15592294.2014.971608","article-title":"TGF-\u03b2 induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells","volume":"9","author":"Cardenas","year":"2014","journal-title":"Epigenetics"},{"issue":"9","key":"10.1016\/j.prp.2026.156398_bib58","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: key players in tumor immune escape and angiogenesis","volume":"72","author":"Facciabene","year":"2012","journal-title":"Cancer Res"},{"issue":"28","key":"10.1016\/j.prp.2026.156398_bib59","doi-asserted-by":"crossref","first-page":"44534","DOI":"10.18632\/oncotarget.10003","article-title":"TGF-\u03b21 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2026.156398_bib60","doi-asserted-by":"crossref","first-page":"690618","DOI":"10.3389\/fonc.2021.690618","article-title":"A SMYD3\/ITGB6\/TGF\u03b21 Positive Feedback Loop Promotes the Invasion and Adhesion of Ovarian Cancer Spheroids","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib61","first-page":"1501","article-title":"Epithelial\u2011mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells","volume":"19","author":"Wang","year":"2019","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib62","first-page":"193","article-title":"A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-\u03b2 derived from ovarian cancer","volume":"39","author":"Fujikake","year":"2018","journal-title":"Oncol Rep"},{"issue":"7","key":"10.1016\/j.prp.2026.156398_bib63","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib64","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.devcel.2008.11.010","article-title":"Hedgehog signaling in development and cancer","volume":"15","author":"Jiang","year":"2008","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1349-7006.2006.00353.x","article-title":"Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it\u2019s inhibition leads to growth suppression and apoptosis","volume":"98","author":"Chen","year":"2007","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib66","first-page":"346","article-title":"Hedgehog signaling pathway and ovarian cancer","volume":"25","author":"Chen","year":"2013","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib67","first-page":"797","article-title":"Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells","volume":"39","author":"Ray","year":"2011","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2009.08.009","article-title":"Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition","volume":"116","author":"Bendoraite","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1757-2215-6-50","article-title":"MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition","volume":"6","author":"Chen","year":"2013","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.prp.2026.156398_bib70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.039","article-title":"Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls","volume":"459","author":"Zhang","year":"2019","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-018-0906-0","article-title":"miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGF\u03b2 pathway","volume":"37","author":"Wang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.prp.2026.156398_bib72","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/IGC.0000000000000546","article-title":"miR-30d Blocked Transforming Growth Factor \u03b21-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells","volume":"25","author":"Ye","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/CBM-181229","article-title":"MiR-27a promotes EMT in ovarian cancer through active Wnt\/?-catenin signalling by targeting FOXO1","volume":"24","author":"Zhang","year":"2019","journal-title":"Cancer Biomark"},{"issue":"7","key":"10.1016\/j.prp.2026.156398_bib74","first-page":"2506","article-title":"Long non-coding RNA H19 mediates ovarian cancer cell cisplatin-resistance and migration during EMT","volume":"12","author":"Wu","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib75","first-page":"3369","article-title":"Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/\u03b2-catenin pathway in epithelial ovarian carcinoma cells","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib76","first-page":"965","article-title":"Role of lncRNA-ATB in ovarian cancer and its mechanisms of action","volume":"19","author":"Yuan","year":"2020","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-025-02338-2","article-title":"Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025","volume":"24","author":"Allgayer","year":"2025","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2026.156398_bib78","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells8101118","article-title":"The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib79","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2021.2005420","article-title":"Dual role of E-cadherin in cancer cells","volume":"10","author":"Rubtsova","year":"2022","journal-title":"Tissue Barriers"},{"issue":"23","key":"10.1016\/j.prp.2026.156398_bib80","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"Roy","year":"2008","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"10","key":"10.1016\/j.prp.2026.156398_bib81","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib82","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1044-579X(02)00057-3","article-title":"Epigenetic versuS Genetic Alterations in the Inactivation of E-Cadherin","volume":"12","author":"Strathdee","year":"2002","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib83","doi-asserted-by":"crossref","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","article-title":"Involvement of members of the cadherin superfamily in cancer","volume":"1","author":"Berx","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib84","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1158\/1078-0432.CCR-07-0487","article-title":"Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer","volume":"14","author":"Winter","year":"2008","journal-title":"Clinical Cancer Res. Official J. American Association Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10549-013-2415-3","article-title":"Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer","volume":"138","author":"Hollestelle","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"13","key":"10.1016\/j.prp.2026.156398_bib86","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.7150\/jca.31329","article-title":"CDC25A facilitates chemo-resistance in ovarian cancer multicellular spheroids by promoting E-cadherin expression and arresting cell cycles","volume":"10","author":"Sun","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib87","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1038\/srep05646","article-title":"Construction and characteristics of an e-cadherin-related three-dimensional suspension growth model of ovarian Cancer","volume":"4","author":"Xu","year":"2014","journal-title":"Sci. Rep."},{"issue":"May","key":"10.1016\/j.prp.2026.156398_bib88","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omto.2019.04.005","article-title":"Restoring E-cadherin expression by natural compounds for anticancer therapies in genital and urinary cancers","volume":"14","author":"Song","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"issue":"46","key":"10.1016\/j.prp.2026.156398_bib89","doi-asserted-by":"crossref","first-page":"81052","DOI":"10.18632\/oncotarget.18898","article-title":"E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"issue":"October","key":"10.1016\/j.prp.2026.156398_bib90","article-title":"Aberrant N-cadherin expression in cancer","volume":"118","author":"Cao","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"April","key":"10.1016\/j.prp.2026.156398_bib91","article-title":"High N-cadherin protein expression in ovarian cancer predicts poor survival and triggers cell invasion","volume":"12","author":"Assidi","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12903","article-title":"Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: a meta-analysis","volume":"48","author":"Luo","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib93","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s12885-018-4845-0","article-title":"N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer","volume":"18","author":"Mrozik","year":"2018","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.prp.2026.156398_bib94","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3390\/cancers13194985","article-title":"Vimentin Is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis","volume":"13","author":"Usman","year":"2021","journal-title":"Cancers"},{"issue":"29","key":"10.1016\/j.prp.2026.156398_bib95","doi-asserted-by":"crossref","first-page":"45876","DOI":"10.18632\/oncotarget.9970","article-title":"Downregulation of vimentin expression increased drug resistance in ovarian cancer cells","volume":"7","author":"Huo","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib96","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/cells9010149","article-title":"Fibronectin and periostin as prognostic markers in ovarian cancer","volume":"9","author":"Kujawa","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.prp.2026.156398_bib97","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12964-020-00580-3","article-title":"Upregulation of fibronectin following Loss of P53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype","volume":"18","author":"Yokoi","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib99","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1878-0261.13556","article-title":"Ovarian cancer relies on the PDGFR\u03b2\u2013fibronectin axis for tumorsphere formation and metastatic spread","volume":"18","author":"Gendrau-Sanclemente","year":"2024","journal-title":"Mol. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2026.156398_bib100","first-page":"2493","article-title":"Fibronectin regulates the dynamic formation of ovarian cancer multicellular aggregates and the expression of integrin receptors","volume":"19","author":"Gong","year":"2018","journal-title":"Asian Pacific J. Cancer Prevention APJCP"},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib101","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jcp.31048","article-title":"Shielding and nurturing: fibronectin as a modulator of cancer drug resistance","volume":"238","author":"Farooq","year":"2023","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib102","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/s41598-025-87388-8","article-title":"Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer","volume":"15","author":"Wani","year":"2025","journal-title":"Sci. Rep."},{"issue":"March","key":"10.1016\/j.prp.2026.156398_bib103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2407-12-91","article-title":"EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer","volume":"12","author":"Haslehurst","year":"2012","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.prp.2026.156398_bib104","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.3390\/ijms241210079","article-title":"The role of EMT-Related lncRNAs in ovarian cancer","volume":"24","author":"Lampropoulou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/cells14030171","article-title":"Similarities in mechanisms of ovarian cancer metastasis and brain glioblastoma multiforme invasion suggest common therapeutic targets","volume":"14","author":"Jackson","year":"2025","journal-title":"Cells"},{"issue":"September","key":"10.1016\/j.prp.2026.156398_bib106","article-title":"The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis","volume":"15","author":"Lei","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156398_bib107","first-page":"2973","article-title":"Links between cancer stem cells and epithelial\u2013mesenchymal transition","author":"Wang","year":"2015","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib108","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.bjc.6605762","article-title":"Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer","volume":"103","author":"Lugli","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib109","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","article-title":"CD44 as a tumor biomarker and therapeutic target","volume":"9","author":"Xu","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"issue":"January","key":"10.1016\/j.prp.2026.156398_bib110","article-title":"EMT, cancer stem cells and autophagy; the three main axes of metastasis","volume":"133","author":"Babaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2026.156398_bib111","doi-asserted-by":"crossref","unstructured":"Marhaba, Rachid, Pamela Klingbeil, Tobias Nuebel, Irina Nazarenko, Markus W. Buechler, and Margot Zoeller. n.d. \u201cCD44 and EpCAM: Cancer-Initiating Cell Markers.\u201d Current Molecular Medicine 8 (8): 784\u2013804. https:\/\/doi.org\/10.2174\/156652408786733667.","DOI":"10.2174\/156652408786733667"},{"issue":"20","key":"10.1016\/j.prp.2026.156398_bib112","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.3390\/ijms252011109","article-title":"Characterization of EpCAM-positive and EpCAM-negative tumor cells in early-stage breast cancer","volume":"25","author":"Perelmuter","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib113","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/biom11081213","article-title":"Cell Adhesion molecules in normal skin and melanoma","volume":"11","author":"D\u2019Arcy","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.prp.2026.156398_bib114","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/carcin\/bgs220","article-title":"EMT-Associated up-Regulation of L1CAM Provides Insights into L1CAM-Mediated Integrin Signalling and NF-\u03baB Activation","volume":"33","author":"Kiefel","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-018-0937-3","article-title":"The functional role of integrins during intra- and extravasation within the metastatic cascade","volume":"18","author":"S\u00f6keland","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"April","key":"10.1016\/j.prp.2026.156398_bib117","article-title":"ThE Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies","volume":"9","author":"Kumar","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2183\/pjab.85.314","article-title":"Transforming growth Factor-\u03b2 signaling in epithelial-mesenchymal transition and progression of cancer","volume":"85","author":"Miyazono","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib119","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1091\/mbc.e04-08-0658","article-title":"TGF-beta and the smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition","volume":"16","author":"Valcourt","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"June","key":"10.1016\/j.prp.2026.156398_bib120","article-title":"Wnt\/\u03b2-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells","volume":"175","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2026.156398_bib121","doi-asserted-by":"crossref","unstructured":"Wang, Zhiwei, Yiwei Li, Dejuan Kong, and Fazlul H. Sarkar. n.d. \u201cThe Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness.\u201d Current Drug Targets 11 (6): 745\u2013751. https:\/\/doi.org\/10.2174\/138945010791170860.","DOI":"10.2174\/138945010791170860"},{"issue":"October","key":"10.1016\/j.prp.2026.156398_bib122","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.2147\/CMAR.S225606","article-title":"Genetic and epigenetic regulation Of E-cadherin signaling in human hepatocellular carcinoma","volume":"11","author":"Fan","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"12","key":"10.1016\/j.prp.2026.156398_bib123","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.3390\/cells10123435","article-title":"Aspects of the epigenetic regulation of EMT related to cancer metastasis","volume":"10","author":"Nowak","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12929-020-00632-3","article-title":"Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-\u03b2 signaling","volume":"27","author":"Lin","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib125","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/ijms22052778","article-title":"Prominent role of histone modifications in the regulation of tumor metastasis","volume":"22","author":"Markouli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib126","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3390\/ijms20082042","article-title":"Role of metabolic reprogramming in epithelial\u2013mesenchymal transition (EMT)","volume":"20","author":"Kang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.prp.2026.156398_bib127","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/febs.14090","article-title":"Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer","volume":"284","author":"Sciacovelli","year":"2017","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"22","key":"10.1016\/j.prp.2026.156398_bib129","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/cbt.10.3.12548","article-title":"\u201cThe Role of the miR-200 family in epithelial-mesenchymal transition.\u201d","volume":"10","author":"Mongroo","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib131","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1038\/s41467-018-07130-z","article-title":"Genetic dissection of the miR-200\u2013Zeb1 axis reveals its importance in tumor differentiation and invasion","volume":"9","author":"Title","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib132","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.201103097","article-title":"A P53\/miRNA-34 axis regulates snail1-dependent cancer cell epithelial\u2013mesenchymal transition","volume":"195","author":"Kim","year":"2011","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib133","article-title":"miR-34a inhibits pancreatic cancer progression through snail1-mediated epithelial\u2013mesenchymal transition and the notch signaling pathway","volume":"7","author":"Tang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib134","first-page":"151","article-title":"LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer","volume":"1856","author":"Bhan","year":"2015","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib135","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/ijms20081924","article-title":"Long Noncoding RNA and epithelial mesenchymal transition in cancer","volume":"20","author":"Gugnoni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib136","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12957-020-02050-z","article-title":"Correction to: LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and notch signaling pathway","volume":"18","author":"He","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"August","key":"10.1016\/j.prp.2026.156398_bib137","article-title":"LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway","volume":"856","author":"Sun","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prp.2026.156398_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104942","article-title":"Role of circular RNAs in regulating tumor microenvironment, epithelial mesenchymal transition, and resistance to cancer therapy","author":"Samad","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.prp.2026.156398_bib139","doi-asserted-by":"crossref","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.prp.2026.156398_bib140","doi-asserted-by":"crossref","first-page":"1113312","DOI":"10.3389\/fimmu.2023.1113312","article-title":"The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.prp.2026.156398_bib141","doi-asserted-by":"crossref","first-page":"1160340","DOI":"10.3389\/fimmu.2023.1160340","article-title":"Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities","volume":"14","author":"Han","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib142","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5480","article-title":"Interaction of tumor\u2011associated macrophages with stromal and immune components in solid tumors: Research progress (Review)","volume":"62","author":"Kazakova","year":"2023","journal-title":"Int J Oncol"},{"key":"10.1016\/j.prp.2026.156398_bib143","article-title":"Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells","author":"Sharrow","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib144","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00280-023-04533-8","article-title":"Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16\/CXCR6 axis","volume":"92","author":"Hong","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.prp.2026.156398_bib145","doi-asserted-by":"crossref","first-page":"109539","DOI":"10.1016\/j.cellsig.2020.109539","article-title":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","volume":"68","author":"El-Arabey","year":"2020","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib146","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI117933","article-title":"The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer","volume":"95","author":"Negus","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.prp.2026.156398_bib147","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.164.2.733","article-title":"Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma","volume":"164","author":"Sica","year":"2000","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib148","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib149","first-page":"999","article-title":"Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1","volume":"3","author":"Chambers","year":"1997","journal-title":"Clin. Cancer. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12864-017-3630-9","article-title":"Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients","volume":"18","author":"Adhikary","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.prp.2026.156398_bib151","first-page":"7","article-title":"The Unique Molecular and Cellular Microenvironment of Ovarian Cancer","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156398_bib152","doi-asserted-by":"crossref","first-page":"566511","DOI":"10.3389\/fonc.2020.566511","article-title":"Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers","volume":"10","author":"Larionova","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib153","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2026.156398_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.04.005","article-title":"Tumor promoting role of anti-tumor macrophages in tumor microenvironment","volume":"316","author":"Goswami","year":"2017","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","article-title":"Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer","volume":"12","author":"Lan","year":"2013","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib156","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","article-title":"Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis","volume":"147","author":"Yuan","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib157","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12766","article-title":"Immune checkpoint inhibitors: The linchpins of modern immunotherapy","volume":"290","author":"Wilky","year":"2019","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib158","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jamaoncol.2018.6258","article-title":"Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial","volume":"5","author":"Disis","year":"2019","journal-title":"JAMA Oncology"},{"issue":"7","key":"10.1016\/j.prp.2026.156398_bib159","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","article-title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study","volume":"30","author":"Matulonis","year":"2019","journal-title":"Ann. Oncol."},{"issue":"24","key":"10.1016\/j.prp.2026.156398_bib160","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.3390\/cancers13246231","article-title":"Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment","volume":"13","author":"Johnson","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060838","article-title":"The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance","volume":"11","author":"Loret","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib162","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib163","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mc.22419","article-title":"CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway","volume":"55","author":"Wang","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"389","key":"10.1016\/j.prp.2026.156398_bib164","doi-asserted-by":"crossref","first-page":"eaal3604","DOI":"10.1126\/scitranslmed.aal3604","article-title":"In vivo imaging reveals a tumor-associated macrophage\u2013mediated resistance pathway in anti\u2013PD-1 therapy","volume":"9","author":"Arlauckas","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.prp.2026.156398_bib165","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/1878-0261.12093","article-title":"New insights into the role of EMT in tumor immune escape","volume":"11","author":"Terry","year":"2017","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib166","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib167","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41551-020-0524-y","article-title":"The expanding landscape of inflammatory cells affecting cancer therapy.","volume":"4","author":"Weissleder","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.prp.2026.156398_bib168","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/cancers11060838","article-title":"The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance","volume":"11","author":"Loret","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41964","article-title":"Targeting epithelial-mesenchymal transition signaling pathways with dietary phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers","volume":"11","author":"Sravani","year":"2025","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib170","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/cancers16081554","article-title":"The role of curcumin in cancer: a focus on the PI3K\/Akt pathway","volume":"16","author":"Zoi","year":"2024","journal-title":"Cancers"},{"issue":"July","key":"10.1016\/j.prp.2026.156398_bib171","article-title":"Natural plants compounds as modulators of epithelial-to-mesenchymal transition","volume":"10","author":"Avila-Carrasco","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.prp.2026.156398_bib172","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijms18122589","article-title":"The role of resveratrol in cancer therapy","volume":"18","author":"Ko","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib173","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/med.21948","article-title":"Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds","volume":"43","author":"Ang","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.prp.2026.156398_bib174","article-title":"Ginsenoside 20(S)-Rg3 targets HIF-1\u03b1 to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2026.156398_bib175","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2020_5343","article-title":"Ginsenoside Rg3 suppresses ovarian cancer cell proliferation and invasion by inhibiting the expression of lncRNA H19","author":"Zhao","year":"2021","journal-title":"Acta Biochim. Pol. 68 (4) 57582"},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib176","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/nu9080911","article-title":"Polyphenolic nutrients in cancer chemoprevention and metastasis: role of the epithelial-to-mesenchymal (EMT) pathway","volume":"9","author":"Amawi","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prp.2026.156398_bib177","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-4943(01)00194-7","article-title":"The curcuma antioxidants: pharmacological effects and prospects for future clinical use. a review","volume":"34","author":"Miquel","year":"2002","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"9","key":"10.1016\/j.prp.2026.156398_bib178","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3390\/pharmaceutics15092223","article-title":"Applications of curcumin and its nanoforms in the treatment of cancer","volume":"15","author":"Mundekkad","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156398_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.934534","article-title":"Curcuminoids as modulators of EMT in invasive cancers: a review of molecular targets with the contribution of malignant mesothelioma studies","volume":"13","author":"Pouliquen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.prp.2026.156398_bib180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037264","article-title":"Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: an integrated study of bioinformatics analysis","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib181","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jsfa.10152","article-title":"Resveratrol: a review of plant sources, synthesis, stability, modification and food application","volume":"100","author":"Tian","year":"2020","journal-title":"J. Sci. Food Agric."},{"issue":"August","key":"10.1016\/j.prp.2026.156398_bib182","article-title":"Therapeutic effects and safety of resveratrol for lung cancer: an updated preclinical systematic review and meta-analysis","volume":"12","author":"Xiao","year":"2025","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.prp.2026.156398_bib183","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3892\/ol.2015.2988","article-title":"Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis","volume":"9","author":"Gao","year":"2015","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib184","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i3.100342","article-title":"Resveratrol and pancreatic cancers: questions and future perspectives","volume":"17","author":"Sukocheva","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"issue":"20","key":"10.1016\/j.prp.2026.156398_bib185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-7847.194044","article-title":"Overviews of biological importance of quercetin: a bioactive flavonoid","volume":"10","author":"Anand","year":"2016","journal-title":"Pharmacogn. Rev."},{"issue":"7","key":"10.1016\/j.prp.2026.156398_bib186","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/nu17071118","article-title":"A narrative review of quercetin\u2019s role as a bioactive compound in female reproductive disorders","volume":"17","author":"Khamineh","year":"2025","journal-title":"Nutrients"},{"issue":"May","key":"10.1016\/j.prp.2026.156398_bib187","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.2147\/IJN.S509877","article-title":"Quercetin and nano-derivatives: potential and challenges in cancer therapy","volume":"20","author":"Li","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42682","article-title":"Phytochemical insights into flavonoids in cancer: mechanisms, therapeutic potential, and the case of quercetin","volume":"11","author":"Silva-Pinto","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2026.156398_bib189","doi-asserted-by":"crossref","unstructured":"Perveen, Shagufta, and Areej Al-Taweel. 2018. Terpenes and Terpenoids. BoD \u2013 Books on Demand.","DOI":"10.5772\/intechopen.71175"},{"issue":"13","key":"10.1016\/j.prp.2026.156398_bib190","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/molecules24132443","article-title":"Chemical structures and pharmacological profiles of ginseng saponins","volume":"24","author":"Shi","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.prp.2026.156398_bib191","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s11033-021-06187-2","article-title":"Insights into the Antitumor Mechanism of Ginsenosides Rg3","volume":"48","author":"Liu","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156398_bib192","doi-asserted-by":"crossref","DOI":"10.1021\/np980259j","article-title":"Alkaloids:\u2009biochemistry, ecology, and medicinal applications edited by margaret F. Roberts (University of London) and Michael Wink (University of Heidelberg). Plenum Press, New York, NY. 1998. Xix + 486 Pp. 16 \u00d7 25 Cm. $115.00. ISBN 0-306-45465-3","volume":"62","author":"Le Quesne","year":"1999","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.prp.2026.156398_bib193","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphar.2018.00557","article-title":"Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders","volume":"9","author":"Neag","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.prp.2026.156398_bib194","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.7150\/jca.118209","article-title":"Latest advancements of natural products in combating ovarian cancer","volume":"16","author":"Lu","year":"2025","journal-title":"J. Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:40:22Z","timestamp":1771544422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382600049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":194,"alternative-id":["S034403382600049X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156398","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156398"}}